BMO Capital Downgrades Chemours (CC) to Underperform
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/25/2026
- Wall Street ends higher as investors buy AI stocks; Microsoft rallies
- Stock action shows confidence in central banks: BofA’s Hartnett
- Oil prices slide about 2% as US, Iran explore path out of war
- Why stocks held up despite rising yields and $100 oil? These 2 words explain it
- Barclays asks if equity markets are nearing the boiling point
- Akamai signs $11.6B deal with Anthropic, up to $20B potential
- Bloom Energy falls as Oracle invokes force majeure on AI project
- Oracle triggers force majeure on massive 'Project Jupiter' data center
- Oracle Sends Force Majeure Notice Over New Mexico Data Center - Bloomberg
- S&P 500 ends marginally lower as investors focus on US-Iran war
Chemours Announces Management Actions and Delay of Form 10-K; Provides Preliminary Unaudited 2023 Year-End Results
February 28, 2024 10:14 PM ESTWILMINGTON, Del.--(BUSINESS WIRE)-- The Board of Directors of The Chemours Company (Chemours or the Company) (NYSE: CC) has appointed Denise Dignam as the Interim Chief Executive Officer and Matt Abbott as the Interim Chief Financial Officer (principal financial and accounting officer).
Ms. Dignam joined Chemours in 2015 and has served as our President Titanium Technologies since March 2023 and previously served as our President Advanced Performance Materials from 2021 to 2023. She previously served as Vice President of Global Operations Fluoroproducts, from 2019 to 2021; Global Senior Business Director Fluoropolymers, from 2016 to 2019; and North American Business Director Diversified Technologies and... More
